In a study published in Autophagy, investigators sought to identify molecules that could become the next generation of therapeutics for pancreatic cancer.
Prior research has shown that microRNA 506 (MIR506) can act as a tumor suppressor in many types of cancer, and can enhance the efficacy of chemotherapy in ovarian cancer. The investigators hypothesized that MIR506 could be a viable option for pancreatic cancer. Read more . . .